Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05992909 · ClinicalTrials.gov registry record
Prophylactic Lymphovenous Bypass Procedure Following Inguinal Lymphadenectomy: A Prospective Observational Study
A clinical trial of Lymphadenectomy, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT05992909: Recruiting study of Lymphadenectomy, sponsored by M.D. Anderson Cancer Center.
NCT05992909 is a study of Lymphadenectomy that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05992909, a study of Lymphadenectomy, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
To learn if LBP can help to prevent lymphedema when it is performed at the time of surgery rather than after a patient has already developed the disease.
Conditions Studied
Interventions
- PROCEDURE Lymphovenous bypass procedure
Study Locations (1)
Texas
- MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2023-08-02 |
| Est. Completion | 2027-08-01 |
What NCT05992909 shows while recruiting
NCT05992909 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 1 condition, with Lymphadenectomy appearing as the primary indexed condition, and to 1 intervention - of which Lymphovenous bypass procedure is the first listed.
NCT05992909 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT05992909 about?
NCT05992909 is a clinical study titled "Prophylactic Lymphovenous Bypass Procedure Following Inguinal Lymphadenectomy: A Prospective Observational Study". To learn if LBP can help to prevent lymphedema when it is performed at the time of surgery rather than after a patient has already developed the disease.
What is the current status of trial NCT05992909?
This trial is currently recruiting. The enrollment target is 20 participants. The study started on 2023-08-02. Estimated completion is 2027-08-01.
What conditions does trial NCT05992909 study?
This clinical trial studies the following conditions: Lymphadenectomy.
What interventions are being tested in trial NCT05992909?
The interventions under investigation include: Lymphovenous bypass procedure (PROCEDURE).
Who is sponsoring clinical trial NCT05992909?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05992909 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI